Grindeks
@grindeks.com
Joint Stock Company Grindeks is an international, vertically integrated pharmaceutical company. The main fields of action are research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. The main therapeutic groups of Grindeks are cardiovascular, central nervous system, anti-cancer and diabetes medicines.
Grindeks's Company Logos
Grindeks's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#6BBE6B
Fern
107, 190, 107
120, 39, 58
44, 0, 44, 25
#CAF880
Mindaro
202, 248, 128
83, 90, 74
19, 0, 48, 3
#222222
Mine Shaft
34, 34, 34
0, 0, 13
0, 0, 0, 87
About Grindeks
Grindeks is the leading pharmaceutical manufacturer in the Baltic States, operating since 1946 and headquartered in Riga, Latvia. With a rich history and a commitment to quality and safety, Grindeks has become a trusted name in the industry. Their products are sold in 100 countries worldwide, helping millions of patients overcome health problems.
Grindeks offers a diverse product portfolio that includes original products, generics, and active pharmaceutical ingredients. They specialize in medications for cardiovascular, central nervous system, oncological, diabetic, and skin diseases. By adhering to world-class safety and quality standards, Grindeks ensures that their medications are effective and reliable.
As part of their growth strategy, Grindeks has established subsidiaries across the globe. Their two main brands, Grindeks and Kalceks, cater to different customer segments. In addition, they have subsidiaries in Lithuania, Estonia, the United States, Canada, Switzerland, and Poland, each contributing to the accessibility and availability of their products.
With a focus on improving people's lives, Grindeks continues to make health solutions accessible to patients worldwide. Trust Grindeks as your partner in healthcare
Company type
Public Company
Year founded
1946
Company size
1001-5000 employees
